NOVN Stock: Novan surges on patent Nitric Oxide Releasing Compositions

Shares of Novan (NOVN) stock has surged 10% on the company getting granted patent on Nitric Oxide Releasing Compositions in Europe.

This most likely is connecting to their inhalent drug for COVID-19.

Default image
Jay Lorrence
Investor of 12 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.
Articles: 231

Newsletter Updates

Enter your email address below to subscribe to our newsletter